McMurray Airway

McMurray Airway

Series

Unknown

First distal pharyngeal airway device for modern patients

First distal pharyngeal airway device for modern patients

FOUNDED

FOUNDED

2019

2019

TOTAL FUNDING

TOTAL FUNDING

TOTAL FUNDING

$50K

$50K

LATEST STAGE

LATEST STAGE

Pre-seed

Pre-seed

2023

2023

HEADCOUNT

HEADCOUNT

1-10

1-10

PRODUCT OVERVIEW

The McMurray Enhanced Airway (MEA) is an FDA-registered disposable distal pharyngeal airway (DPA) (the first of its kind) invented to address a clinical void in basic airway management that existing oral and nasal airways, largely unchanged for nearly a century, fail to fill. The device is inserted between the molars and extends into the distal pharynx to stent open the airway beyond the tongue, facilitating oxygenation, ventilation, and intraoral positive pressure ventilation without the mask-fit variables that create challenges with obese, bearded, or edentulous patients. Its three primary use cases are upper airway obstruction management during endoscopic procedures, difficult mask ventilation support, and apneic oxygenation during intubation thus making it applicable across anesthesia, PACU, ICU, EMS, and emergency settings.

Show more

NURSE FOUNDER

COMPANY INFO

Status

Active

HQ

Minneapolis, MN

Category

Medical Devices

Profile claimed?

Unclaimed

INVESTORS

Lead

ACCELERATORS

PRODUCT OVERVIEW

The McMurray Enhanced Airway (MEA) is an FDA-registered disposable distal pharyngeal airway (DPA) (the first of its kind) invented to address a clinical void in basic airway management that existing oral and nasal airways, largely unchanged for nearly a century, fail to fill. The device is inserted between the molars and extends into the distal pharynx to stent open the airway beyond the tongue, facilitating oxygenation, ventilation, and intraoral positive pressure ventilation without the mask-fit variables that create challenges with obese, bearded, or edentulous patients. Its three primary use cases are upper airway obstruction management during endoscopic procedures, difficult mask ventilation support, and apneic oxygenation during intubation thus making it applicable across anesthesia, PACU, ICU, EMS, and emergency settings.

FUNDING TIMELINE

Funding timeline here

Funding timeline here

IN THE NEWS

NURSE FOUNDER

COMPANY INFO

Status

Active

HQ

Minneapolis, MN

Category

Medical Devices

Profile claimed?

Unclaimed

INVESTORS

None